Amytrx Therapeutics is advancing a new class of peptide therapies to overcome inflammatory diseases—with a vision of providing transformative medicines to patients.

Biotechnology

Amytrx Therapeutics

Amytrx Therapeutics' headquarters in Nashville, TN, United States

The Birmingham office serves as a strategic hub for executive leadership and decision-making in the southeastern U.S.

Birmingham

Matthew A. Gonda

Danny O. Helton

Vernon L. Alvarez

Shima Joshi

Randall B. Riggs

Lawrence W. Greer

Daniel D. Canale

Jacek Hawiger

Dennis J. Carlo

Raymond Pirtle

Thomas G. Andrews

G. William Coble

The Leadership Team at Amytrx Therapeutics is responsible for setting strategic direction and overseeing the development of innovative peptide therapies for inflammatory diseases. This team, composed of experts in chemistry, manufacturing, regulatory affairs, and business development, collaborates to ensure the successful advancement of projects from research through to commercialization, while upholding the company’s vision of delivering transformative medicines to patients.

Leadership Team

The Directors Team at Amytrx Therapeutics is responsible for strategic oversight, governance, and guiding the company's mission to develop transformative peptide therapies for inflammatory diseases. This team ensures alignment on vision, operational excellence, and regulatory compliance while fostering innovation and growth.

Directors Team

The Regulatory and Chemistry team at Amytrx Therapeutics ensures compliance with industry regulations and advances peptide chemistry innovations for therapeutic development. They oversee regulatory affairs, peptide synthesis, and the manufacturing processes to bring transformative anti-inflammatory medicines to patients.

Amytrx Therapeutics

Org chart

Board & advisors

Teams

Leadership Team

Directors Team

Regulatory and Chemistry

Offices

Amytrx Therapeutics

Org chart

Board & advisors

Teams

Leadership Team

Directors Team

Regulatory and Chemistry

Offices

Related companies